Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PKLR inhibition in the treatment of NAFLD and HCC

PKLR inhibition in the treatment of NAFLD and HCC

US Patent 11034960 · Granted Jun 15, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substances for treatment of fatty liver-related conditions2023
Substances for treatment of fatty liver-related conditions2023
Substances for treatment of fatty liver-related conditions2021
Substances for treatment of fatty liver-related conditions2021
Methods and tools for identifying compounds which modulate atherosclerosis by im2006
Methods and tools for identifying compounds which modulate atherosclerosis by im2005
Methods and tools for identifying compounds which modulate atherosclerosis by im2003